Free Trial
NASDAQ:EVFM

Evofem Biosciences (EVFM) Stock Price, News & Analysis

Evofem Biosciences logo
$0.01 +0.00 (+0.70%)
As of 03:54 PM Eastern

About Evofem Biosciences Stock (NASDAQ:EVFM)

Advanced

Key Stats

Today's Range
$0.0140
$0.0145
50-Day Range
$0.0089
$0.0155
52-Week Range
$0.0061
$0.0160
Volume
695,721 shs
Average Volume
441,737 shs
Market Capitalization
$1.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evofem Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

EVFM MarketRank™: 

Evofem Biosciences scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Evofem Biosciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evofem Biosciences is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evofem Biosciences is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.01% of the float of Evofem Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Evofem Biosciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Evofem Biosciences has recently increased by 5,533.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Evofem Biosciences does not currently pay a dividend.

  • Dividend Growth

    Evofem Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.01% of the float of Evofem Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Evofem Biosciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Evofem Biosciences has recently increased by 5,533.33%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 1 people have searched for EVFM on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Evofem Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.01% of the stock of Evofem Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 0.22% of the stock of Evofem Biosciences is held by institutions.

  • Read more about Evofem Biosciences' insider trading history.
Receive EVFM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVFM Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

EVFM Stock Analysis - Frequently Asked Questions

Evofem Biosciences' stock was trading at $0.0099 at the beginning of 2025. Since then, EVFM stock has increased by 44.4% and is now trading at $0.0143.

Evofem Biosciences, Inc. (NASDAQ:EVFM) issued its earnings results on Friday, June, 16th. The biotechnology company reported ($1.85) EPS for the quarter, topping analysts' consensus estimates of ($15.00) by $13.15. The biotechnology company had revenue of $5.81 million for the quarter. Evofem Biosciences had a negative net margin of 46.42% and a negative trailing twelve-month return on equity of 91.97%.

Evofem Biosciences's stock reverse split on the morning of Thursday, May 18th 2023.The 1-125 reverse split was announced on Thursday, May 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of EVFM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evofem Biosciences investors own include Tesla (TSLA), NIO (NIO), Plug Power (PLUG), Meta Platforms (META), Sorrento Therapeutics (SRNE), NVIDIA (NVDA) and Ford Motor (F).

Company Calendar

Last Earnings
6/16/2023
Today
9/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EVFM
CIK
1618835
Employees
120
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.98 million
Net Margins
-46.42%
Pretax Margin
-46.42%
Return on Equity
-91.97%
Return on Assets
-61.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$11.39 million
Price / Sales
0.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.64) per share
Price / Book
-0.01

Miscellaneous

Outstanding Shares
123,956,000
Free Float
113,118,000
Market Cap
$1.77 million
Optionable
Not Optionable
Beta
-1.11

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:EVFM) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners